Jude Waterbury
Internal Medicine · Elk Grove, CANPI 1487626594
Payments from drug & device makers
Across 273 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$935
- AbbVie$708
- Novo Nordisk$412
- Johnson & Johnson$250
- Merck$202
- Boehringer Ingelheim$167
- plus $2K from 36 others
What the payments were for
- Food & beverage$4,758100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 46 | $935 |
| AbbVie(2 entities) | 42 | $708 |
| Novo Nordisk | 24 | $412 |
| Johnson & Johnson | 17 | $250 |
| Merck | 11 | $202 |
| Boehringer Ingelheim | 10 | $167 |
| Pfizer | 9 | $158 |
| Sanofi-aventis U.S. LLC | 11 | $155 |
| Mannkind Corporation | 11 | $154 |
| Gilead | 7 | $150 |
| Lilly USA, LLC | 8 | $136 |
| Abbott | 8 | $135 |
| AstraZeneca | 9 | $130 |
| Hologic Sales And Service, LLC | 7 | $126 |
| Boston Scientific | 4 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Amarin Pharma, Inc. | 4 | $70 |
| Therapeuticsmd, Inc. | 4 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| Biohaven Pharmaceuticals, Inc. | 3 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $46 |
| Bausch Health US, LLC | 3 | $43 |
| Astellas Pharma US Inc | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Eisai Inc. | 2 | $33 |
| Medtronic | 2 | $33 |
| Novartis | 2 | $31 |
| Bioventus LLC | 1 | $28 |
| Amgen | 1 | $27 |
| Almatica Pharma LLC | 1 | $26 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Assertio Therapeutics, Inc. | 1 | $21 |
| Smith+Nephew | 1 | $21 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Organon | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| Medicure Pharma Inc. | 1 | $10 |
How this compares
$4,771 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 81 | $102,803 |
| EliquisApixaban | 89 | $79,592 |
| JardianceEmpagliflozin | 58 | $79,044 |
| OzempicSemaglutide | 56 | $56,599 |
| TrulicityDulaglutide | 29 | $44,988 |
| XareltoRivaroxaban | 44 | $38,987 |
| FarxigaDapagliflozin Propanediol | 19 | $28,679 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $28,219 |
| InvokanaCanagliflozin | 16 | $26,655 |
| Spiriva HandihalerTiotropium Bromide | 31 | $22,468 |
| TradjentaLinagliptin | 12 | $15,663 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $8,127 |
| Atorvastatin Calcium | 623 | $7,636 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 61 | $7,094 |
| MyrbetriqMirabegron | 11 | $6,851 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $202 | $102,80381 claims |
| Boehringer IngelheimJardiance, Tradjenta | $167 | $94,70770 claims |
| PfizerEliquis, Premarin | $158 | $82,183101 claims |
| Johnson & JohnsonXarelto, Invokana | $250 | $65,64260 claims |
| Novo NordiskOzempic | $412 | $56,59956 claims |
| Lilly USA, LLCTrulicity | $136 | $44,98829 claims |
| AstraZenecaFarxiga | $130 | $28,67919 claims |
| GSKTrelegy Ellipta | $935 | $28,21933 claims |
| Astellas Pharma US IncMyrbetriq | $42 | $6,85111 claims |
| AbbVieSynthroid | $708 | $3,07829 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Elk Grove
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- Donald BrandonSan Diego$34M
- William TownerLos Angeles$27.4M
- Rahul AggarwalSan Francisco$24M
- Masoud AzizadNorthridge$21.1M
- Helen StaceyWalnut Creek$20.4M
- Rohit Loombala Jolla$15.1M
- Zeid KayaliColton$14.2M
- Alexandra DrakakiSanta Monica$14.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.